IDEXX LABORATORIES INC /DE (IDXX) Operating income 2016–2025
IDEXX LABORATORIES INC /DE (IDXX) annual operating income history from SEC filings — each fiscal year as reported.
$1.4BFY2025 · since FY2016: $350.2M → $1.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.4B | +20.5% |
| FY2024 | $1.1B | +2.8% |
| FY2023 | $1.1B | +22.1% |
| FY2022 | $898.8M | -3.6% |
| FY2021 | $932.0M | +34.2% |
| FY2020 | $694.5M | +25.6% |
| FY2019 | $552.8M | +12.5% |
| FY2018 | $491.3M | +19.0% |
| FY2017 | $413.0M | +17.9% |
| FY2016 | $350.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IDXX financial trends
IDXX RevenueIDXX Net incomeIDXX Net marginIDXX Gross profitIDXX Gross marginIDXX Operating marginIDXX Operating cash flowIDXX Free cash flowIDXX Capital expendituresIDXX Return on equityIDXX Stock buybacksIDXX Dividends paidIDXX Total assetsIDXX Total liabilitiesIDXX Shareholders’ equityIDXX overview →